The Effects of the GOLO for Life® Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Adults With Prediabetes or Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT05844644
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Sponsor
- Golo
- Registry
-
NCT05844644
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Unknown status
Technical summary
Registry record NCT05844644. Allocation not applicable; no masking; primary purpose treatment. Start 2023-04-20 (actual); primary completion 2024-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effects of the GOLO for Life® Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Adults With Prediabetes or Type 2 Diabetes
- Condition
- Type 2 Diabetes
- Condition
- Obese
- Condition
- Overweight
- Condition
- Prediabetes
- Intervention (Dietary supplement)
- Release
- Lead sponsor
- Golo
- Collaborator
- KGK Science Inc.
Record details
- Record id
cardio:ct-nct05844644- Content hash
45b6596e825cbf7ad01804358c585e19c6f2733233e8f7fbb697361d6bee8441